About this trial
Patient Profile
Any metastatic cancer of unknown primary site which had been treated with three cycles of platinum doublet chemotherapy.
Where’s this trial being run?
University Hospital Waterford
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | CUPISCO |
|---|---|
| Number: | CTRIAL-IE 18-29 |
| Full Title: | Phase II, randomized, active-controlled, multi-center study comparing the efficacy and safety of targeted therapy or cancer immunotherapy guided by genomic profiling versus platinum-based chemotherapy in patients with cancer of unknown primary site who have received three cycles of platinum doublet chemotherapy |
| Principal Investigator: | Miriam O'Connor |
|---|---|
| Type: | Industry Sponsored |
| Sponsor: | Roche |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | 790 |
|---|---|
| Ireland Recruitment Target: |